Cencora Total Current Assets 2010-2025 | COR
Cencora total current assets from 2010 to 2025. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
- Cencora total current assets for the quarter ending March 31, 2025 were $46.535B, a 5.38% increase year-over-year.
- Cencora total current assets for 2024 were $47.718B, a 11.49% increase from 2023.
- Cencora total current assets for 2023 were $42.799B, a 8.11% increase from 2022.
- Cencora total current assets for 2022 were $39.59B, a 2.03% increase from 2021.
| Cencora Annual Total Current Assets (Millions of US $) |
|
|---|---|
| 2024 | $47,718 |
| 2023 | $42,799 |
| 2022 | $39,590 |
| 2021 | $38,803 |
| 2020 | $33,056 |
| 2019 | $28,132 |
| 2018 | $25,894 |
| 2017 | $24,303 |
| 2016 | $22,852 |
| 2015 | $20,334 |
| 2014 | $16,800 |
| 2013 | $14,394 |
| 2012 | $11,058 |
| 2011 | $11,375 |
| 2010 | $10,748 |
| 2009 | $9,954 |
| Cencora Quarterly Total Current Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $46,535 |
| 2024-12-31 | $49,987 |
| 2024-09-30 | $47,718 |
| 2024-06-30 | $47,307 |
| 2024-03-31 | $44,161 |
| 2023-12-31 | $44,859 |
| 2023-09-30 | $42,799 |
| 2023-06-30 | $40,987 |
| 2023-03-31 | $39,990 |
| 2022-12-31 | $40,708 |
| 2022-09-30 | $39,590 |
| 2022-06-30 | $39,745 |
| 2022-03-31 | $39,410 |
| 2021-12-31 | $39,379 |
| 2021-09-30 | $38,803 |
| 2021-06-30 | $37,260 |
| 2021-03-31 | $35,469 |
| 2020-12-31 | $34,700 |
| 2020-09-30 | $33,056 |
| 2020-06-30 | $29,919 |
| 2020-03-31 | $31,181 |
| 2019-12-31 | $28,955 |
| 2019-09-30 | $28,132 |
| 2019-06-30 | $27,402 |
| 2019-03-31 | $27,622 |
| 2018-12-31 | $27,476 |
| 2018-09-30 | $25,894 |
| 2018-06-30 | $26,404 |
| 2018-03-31 | $26,397 |
| 2017-12-31 | $25,296 |
| 2017-09-30 | $24,303 |
| 2017-06-30 | $23,677 |
| 2017-03-31 | $23,494 |
| 2016-12-31 | $23,079 |
| 2016-09-30 | $22,852 |
| 2016-06-30 | $21,457 |
| 2016-03-31 | $22,070 |
| 2015-12-31 | $20,362 |
| 2015-09-30 | $20,334 |
| 2015-06-30 | $19,902 |
| 2015-03-31 | $19,557 |
| 2014-12-31 | $20,145 |
| 2014-09-30 | $16,800 |
| 2014-06-30 | $15,891 |
| 2014-03-31 | $15,760 |
| 2013-12-31 | $15,228 |
| 2013-09-30 | $14,394 |
| 2013-06-30 | $12,139 |
| 2013-03-31 | $11,725 |
| 2012-12-31 | $11,022 |
| 2012-09-30 | $11,058 |
| 2012-06-30 | $11,170 |
| 2012-03-31 | $11,604 |
| 2011-12-31 | $11,956 |
| 2011-09-30 | $11,375 |
| 2011-06-30 | $11,121 |
| 2011-03-31 | $10,956 |
| 2010-12-31 | $10,428 |
| 2010-09-30 | $10,748 |
| 2010-06-30 | $10,338 |
| 2010-03-31 | $10,167 |
| 2009-12-31 | $9,916 |
| 2009-09-30 | $9,954 |
| 2009-06-30 | $9,138 |
| 2009-03-31 | $9,005 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $56.019B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.181B | 25.92 |
| Elevance Health (ELV) | United States | $85.871B | 11.08 |
| CVS Health (CVS) | United States | $80.417B | 10.00 |
| Natera (NTRA) | United States | $22.833B | 0.00 |
| DiDi Global (DIDIY) | China | $22.168B | 33.64 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| Solventum (SOLV) | United States | $13.000B | 13.76 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.955B | 0.00 |
| CochLear (CHEOY) | Australia | $11.511B | 0.00 |
| ICON (ICLR) | Ireland | $11.274B | 10.48 |
| Revvity (RVTY) | United States | $10.891B | 18.74 |
| Doximity (DOCS) | United States | $10.250B | 47.45 |
| Viatris (VTRS) | United States | $10.082B | 3.46 |
| HealthEquity (HQY) | United States | $9.777B | 42.83 |
| Avantor (AVTR) | United States | $9.070B | 13.18 |
| Medpace Holdings (MEDP) | United States | $8.989B | 23.87 |
| Sonic Healthcare (SKHHY) | Australia | $8.365B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.034B | 13.78 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| BrightSpring Health Services (BTSG) | United States | $4.109B | 38.03 |
| Bausch + Lomb (BLCO) | Canada | $4.068B | 23.98 |
| Sotera Health (SHC) | United States | $3.508B | 19.93 |
| Alignment Healthcare (ALHC) | United States | $3.031B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.955B | 38.43 |
| Concentras Parent (CON) | United States | $2.766B | 15.98 |
| Organon (OGN) | United States | $2.477B | 2.63 |
| Ardent Health Partners (ARDT) | United States | $2.084B | 8.88 |
| GeneDx Holdings (WGS) | United States | $2.066B | 79.55 |
| Premier (PINC) | United States | $1.908B | 14.48 |
| Progyny (PGNY) | United States | $1.826B | 40.19 |
| PACS (PACS) | United States | $1.550B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.432B | 28.64 |
| Teladoc Health (TDOC) | United States | $1.249B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.194B | 9.09 |
| Establishment Labs Holdings (ESTA) | $1.075B | 0.00 | |
| CareDx (CDNA) | United States | $1.075B | 16.78 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.907B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.768B | 7.19 |
| QDM (QDMI) | Hong Kong, SAR China | $0.755B | 0.00 |
| Nutex Health (NUTX) | United States | $0.753B | 11.41 |
| Embecta (EMBC) | United States | $0.608B | 4.09 |
| LifeMD (LFMD) | United States | $0.559B | 0.00 |
| Enhabit (EHAB) | United States | $0.538B | 44.25 |
| InnovAge Holding (INNV) | United States | $0.535B | 0.00 |
| SBC Medicals (SBC) | United States | $0.502B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.486B | 10.95 |
| Sonida Senior Living (SNDA) | United States | $0.460B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.423B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.240B | 0.00 |
| Beauty Health (SKIN) | United States | $0.210B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.147B | 24.00 |
| KindlyMD (NAKA) | United States | $0.103B | 0.00 |
| So-Young (SY) | China | $0.097B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.084B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.073B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.046B | 0.00 |
| Biodesix (BDSX) | United States | $0.043B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |